SCHEMBL14410285

SCHEMBL14410285

Cc1cc(C(C)C)cc(F)c1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ADRB2 P07550 4/20 0.36
EIF4A3 P38919 1/20 0.35
LMNA P02545 1/20 0.34
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
ADRB1 P08588 1/20 0.33
TRPA1 O75762 1/20 0.33
PTGS1 P23219 1/20 0.33
CACNA1C Q13936 1/20 0.33
GAA P10253 1/20 0.32
ALOX12 P18054 1/20 0.32
HTT P42858 1/20 0.32
HIF1A Q16665 1/20 0.32
POLB P06746 1/20 0.32
ADRA2A P08913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18925631 0.86 ADRB2 (0.40) ALDH1A1ADRB2EIF4A3LMNAGABRA1
SCHEMBL1596387 0.84 ALDH1A1 (0.39) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL1183197 0.84 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4TSHRTDP1
Hydrochloric Acid SCHEMBL7982604 0.81 ALDH1A1 (0.50) ALDH1A1TP53CYP3A4TSHRTDP1
Hydrochloric Acid SCHEMBL28293183 0.81 ALDH1A1 (0.50) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL21479474 0.77 EIF4A3 (0.37) EIF4A3LMNAGABRA1GABRB2TRPA1
SCHEMBL6124154 0.77 EIF4A3 (0.37) EIF4A3LMNAGABRA1GABRB2TRPA1
SCHEMBL10342100 0.77 ALDH1A1 (0.43) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL14410289 0.77 CA1 (0.44) ALDH1A1ADRB2EIF4A3GABRA1GABRB2
SCHEMBL24115940 0.76 GABRA1 (0.43) ALDH1A1TP53CYP3A4TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070208036-A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-09-06 US disclosed
US-7230001-B1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208036-A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them ARRB1, NPY1R, ADRB3 ALDH1A1 425/4885TP53 4336/4885CYP3A4 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.